Cargando…

Enoxaparin’s potential mechanisms against SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Afsharirad, Bentelhoda, Entezari-Maleki, Taher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389436/ https://www.ncbi.nlm.nih.gov/pubmed/36799791 http://dx.doi.org/10.1097/JS9.0000000000000081

Ejemplares similares

SARS-CoV-2 and probable lung cancer risk
por: Khiali, Sajad, et al.
Publicado: (2022)

Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’
por: Khani, Elnaz, et al.
Publicado: (2023)

Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists
por: Khani, Elnaz, et al.
Publicado: (2022)

SARS-CoV-2: Receptor and Co-receptor Tropism Probability
por: Eslami, Narges, et al.
Publicado: (2022)

Potential implications of SARS-CoV-2 on pregnancy
por: Tseng, Jen-Yu
Publicado: (2020)

Chloroquine drops against SARS-CoV-2 infection
por: Kumar, Jogender, et al.
Publicado: (2022)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis
por: Aghbash, Parisa Shiri, et al.
Publicado: (2021)

Fighting the Battle against SARS-CoV-2 as Gastroenterologists in Italy
por: Pagnini, Cristiano, et al.
Publicado: (2020)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs
por: Rasizadeh, Reyhaneh, et al.
Publicado: (2023)

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
por: Tandon, Ritesh, et al.
Publicado: (2020)

SARS-CoV 2 and the pathobiology of the respiratory control mechanisms in the brainstem
por: Mishra, Rakesh, et al.
Publicado: (2021)

Ebselen, a new candidate therapeutic against SARS-CoV-2
por: Haritha, C.V., et al.
Publicado: (2020)

Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
por: Fang, Zhenhao, et al.
Publicado: (2022)

Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
por: Wang, Pei-Gang, et al.
Publicado: (2020)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Prone positioning in intubated and mechanically ventilated patients with SARS-CoV-2
por: Chen, Yaping, et al.
Publicado: (2021)

SARS-CoV-2 in semen: Potential for sexual transmission in COVID-19
por: Sharun, Khan, et al.
Publicado: (2020)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
por: Chemaitelly, Hiam, et al.
Publicado: (2021)

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants
por: Pallett, Scott J C, et al.
Publicado: (2022)

Cross-reactive antibody immunity against SARS-CoV-2 in children and adults
por: Fraley, Elizabeth, et al.
Publicado: (2021)

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2
por: Takashita, Emi, et al.
Publicado: (2022)

SARS-CoV-2 shedding and infectivity
por: Atkinson, Barry, et al.
Publicado: (2020)

The proximal origin of SARS-CoV-2
por: Andersen, Kristian G., et al.
Publicado: (2020)

SARS-CoV-2 Infection in Children
por: Lu, Xiaoxia, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain
por: George, Thukalan Paulose
Publicado: (2020)

SARS CoV2 vaccine and aphasia
por: sookaromdee, Pathum, et al.
Publicado: (2021)

Hybrid SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in Spain
por: Hoffmann, Christian, et al.
Publicado: (2020)

In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin
por: Alroomi, Moudhi, et al.
Publicado: (2022)

SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability
por: Foster, Charles S.P., et al.
Publicado: (2022)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

Gastrointestinal involvement of COVID-19 and potential faecal transmission of SARS-CoV-2
por: Song, Min, et al.
Publicado: (2020)

SARS-CoV-2 in wastewater: potential health risk, but also data source
por: Lodder, Willemijn, et al.
Publicado: (2020)

An action plan for pan-European defence against new SARS-CoV-2 variants
por: Priesemann, Viola, et al.
Publicado: (2021)

Proposing a nasal trehalose‐induced autophagy approach against SARS‐CoV 2
por: Pajokh, Mojde, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3sne4js8cftovf4og8kp6p5olo